Witnessing the stock’s movement on the chart, on Wednesday, Abbott Laboratories (NYSE: ABT) had a quiet start as it plunged -0.82% to $125.29, before settling in for the price of $126.32 at the close. Taking a more long-term approach, ABT posted a 52-week range of $110.86-$141.23.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 29.98%. Meanwhile, its Annual Earning per share during the time was 29.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.32%. This publicly-traded company’s shares outstanding now amounts to $1.74 billion, simultaneously with a float of $1.73 billion. The organization now has a market capitalization sitting at $217.86 billion. At the time of writing, stock’s 50-day Moving Average stood at $128.97, while the 200-day Moving Average is $130.96.
Abbott Laboratories (ABT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Abbott Laboratories’s current insider ownership accounts for 0.67%, in contrast to 80.57% institutional ownership. According to the most recent insider trade that took place on Nov 25 ’25, this organization’s Senior Vice President sold 1,586 shares at the rate of 128.02, making the entire transaction reach 203,043 in total value, affecting insider ownership by 30,384.
Abbott Laboratories (ABT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.2 per share during the current fiscal year.
Abbott Laboratories’s EPS increase for this current 12-month fiscal period is 10.32% and is forecasted to reach 5.67 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.30% through the next 5 years, which can be compared against the 29.98% growth it accomplished over the previous five years trading on the market.
Abbott Laboratories (NYSE: ABT) Trading Performance Indicators
Let’s observe the current performance indicators for Abbott Laboratories (ABT). It’s Quick Ratio in the last reported quarter now stands at 1.24. Alongside those numbers, its PE Ratio stands at $15.72, and its Beta score is 0.72. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.97. Similarly, its price to free cash flow for trailing twelve months is now 31.50.
In the same vein, ABT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 7.97, a figure that is expected to reach 1.50 in the next quarter, and analysts are predicting that it will be 5.67 at the market close of one year from today.
Technical Analysis of Abbott Laboratories (ABT)
Going through the that latest performance of [Abbott Laboratories, ABT]. Its last 5-days volume of 4.84 million was inferior to the volume of 6.59 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 48.58% While, its Average True Range was 39.59.
Raw Stochastic average of Abbott Laboratories (ABT) in the period of the previous 100 days is set at 31.15%, which indicates a major fall in contrast to 32.18% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.87 that was higher than 2.52 volatility it exhibited in the past 100-days period.
